IMACS Accessible imaging : shaping the future of imaging
- Coordinator
- Universite D'aix Marseille, France
- Runs
- 1 June 2026 to 31 May 2031
- Status
- Running
- EU funding
- €2.9m
- Total cost
- —
- Partners
- 47 organisations in 13 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101261856
What the project is doing
In the project's own words, from its summary on CORDIS.
Biomedical imaging is crucial for advances in life sciences and in medicine, particularly for diagnosing and monitoring major diseases. Challenges hinder a widespread use of imaging tools, such as the lack of accessible equipment, efficient examinations, geographical inequalities, and the exclusion of certain population groups. Ensuring imaging capabilities to reach underserved populations and territories is essential.
This is not just a matter of technology, but one of equity and global health impact. The IMACS program is designed to address these challenges, over 54-months, by training a new generation of researchers specialised in biomedical imaging and offering them an excellent research environment within Aix Marseille University (AMU), the University of Tubingen (UT) and a network of 80 academic and 61 non-academic partners including 5 hospitals.
The program seeks to recruit 17 experienced researchers (ERs) for 36-month bottom-up projects through a transparent and merit-based selection process. It focuses on three dimensions: 1. Interdisciplinary and international training: To train researchers capable of working in interdisciplinary and international environments, combining research and innovation across all imaging modalities, with international secondments. 2.
Socio-economic integration: To prepare researchers for academic challenges in imaging and integrate them into medical technology development and health sectors in biomedical imaging while facilitating their intersectoral immersion. 3. Promotion of innovation: To encourage ambitious projects that enhance accessible imaging technologies (hardware and digital tools), aiming at equal healthcare access while strengthening Europe’s competitiveness in medical technology.
Overall, IMACS Programme is a key element in the broader transformation strategy of postgraduate training at AMU and UT, aligning with regional, national, and European priorities.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite D'aix Marseille | Marseille | France | Coordinator |
| The University of Queensland | Brisbane | Australia | Associatedpartner |
| University of British Columbia | Vancouver | Canada | Associatedpartner |
| Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | Associatedpartner |
| Universite De Geneve | Geneve | Switzerland | Associatedpartner |
| European Molecular Biology Laboratory | Heidelberg | Germany | Associatedpartner |
| Friedrich-Alexander-Universitaet Erlangen-Nuernberg | Erlangen | Germany | Associatedpartner |
| Friedrich-Schiller-Universität Jena | Jena | Germany | Associatedpartner |
| Karlsruher Institut Fuer Technologie | Karlsruhe | Germany | Associatedpartner |
| Leibniz-Institut Fuer Photonische Technologien E.v. | Jena | Germany | Associatedpartner |
| Martin-Luther-Universitat Halle-Wittenberg | Halle | Germany | Associatedpartner |
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Associatedpartner |
| Nvision Quantum Technologies GmbH | Ulm | Germany | Associatedpartner |
| SI Stuttgart Instruments GmbH | Stuttgart | Germany | Associatedpartner |
| Siemens Healthineers AG | Forchheim | Germany | Associatedpartner |
| Vicinity Bio GmbH | Tübingen | Germany | Associatedpartner |
| Universidad Autonoma De Madrid | Madrid | Spain | Associatedpartner |
| Ita-Suomen Yliopisto | Kuopio | Finland | Associatedpartner |
| A5 Science | Aix En Provence | France | Associatedpartner |
| Advanced Accelerator Applications Molecular Imaging France S.A.S | Saint-Genis-Pouilly | France | Associatedpartner |
| Centre Hospitalier Regional De Marseille Assistance Publique-Hopitaux Marseille | Marseille Cedex 20 | France | Associatedpartner |
| Deepcolor | Nantes | France | Associatedpartner |
| Fondation Universitaire AMIDEX | Marseille | France | Associatedpartner |
| Ge Medical Systems Scs | Buc | France | Associatedpartner |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Associatedpartner |
| Kaer Labs SAS | Nantes | France | Associatedpartner |
| Lightcore Technologies | Marseille | France | Associatedpartner |
| Multiwave Technologies | Marseille | France | Associatedpartner |
| Olea Medical | La Ciotat | France | Associatedpartner |
| Orano Support | Chatillon | France | Associatedpartner |
| Siemens Healthcare SAS | Courbevoie | France | Associatedpartner |
| Silon Therapeutics | Marseille | France | Associatedpartner |
| Solnil | Marseille | France | Associatedpartner |
| Istituto Romagnolo per Lo Studio Dei Tumori Dino Amadori - Irst SRL | Meldola | Italy | Associatedpartner |
| Politecnico Di Milano | Milano | Italy | Associatedpartner |
| Technische Universiteit Delft | Delft | Netherlands | Associatedpartner |
| Raphael Samuel Matthew Kaplan | Trondheim | Norway | Associatedpartner |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Associatedpartner |
| King's College London | London | United Kingdom | Associatedpartner |
| The University of Birmingham | Birmingham | United Kingdom | Associatedpartner |
| Florida International University | Miami | United States | Associatedpartner |
| Memorial Sloan Kettering Cancer Center | New York City | United States | Associatedpartner |
| The Regents of the University of California | Oakland | United States | Associatedpartner |
| The Trustees of the University of Pennsylvania Corp | Philadelphia | United States | Associatedpartner |
| Trustees of Purdue University | West Lafayette | United States | Associatedpartner |
| Trustees of Boston University | Boston | United States | Associatedpartner |
| Truong Dai Hoc Khoa Hoc Va Cong Nghe Ha Noi | Hanoi | VN | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI